l9n/ Oregon

2015 Regular Session

House Bill 2026

Permits pharmacist to substitute interchangeable biosimilar products for certain prescribed biological products.

Did not become law. It stopped in the House of Representatives's Health Care Committee on July 6, 2015. The 2015 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Permits pharmacist to substitute interchangeable biosimilar products for certain prescribed biological products. Directs State Board of Pharmacy to adopt rules to define "biological product," "biosimilar product" and "interchangeable" for purposes of prescription substitutions. Becomes operative January 1, 2016. Declares emergency, effective on passage.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

    1 co-sponsor

    HHC

    Its course

    February 18 to July 6, 2015, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

    Each committee stop sits inside its chamber.

    Every action4 actions on 4 days

    In the House of RepresentativesFeb 18 to Jul 6 · stopped138 days

    Waiting for a committeeFeb 18 to Feb 246 days

    Health CareFeb 24 to Jul 6 · stopped132 days

    Text

    Each version as the Legislative Assembly printed it.

    l9n doesn't hold this bill's text yet.

    What happened

    In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

    In the House of Representatives Feb 18 – Jul 6

    1. Feb 18Introduced
    2. Feb 24Sent to Health Care
    3. Mar 16Heard in Health Care
    4. Jul 6Died when the session ended
    All 4 actions, as published
    1. Feb 18First reading. Referred to Speaker's desk.House of Representatives
    2. Feb 24Referred to Health Care.House of Representatives
    3. Mar 16Public Hearing held.House of Representatives
    4. Jul 6In committee upon adjournment.House of Representatives